| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $58.6M | +25.7% |
| SG&A Expense | $12.3M | -18.1% |
| Operating Income | -$70.9M | -15.0% |
| Interest Expense | $14K | -99.1% |
| Net Income | -$73.5M | -11.3% |
| EPS (Basic) | -$0.69 | +5.5% |
| EPS (Diluted) | -$0.69 | +5.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $22.7M | -72.8% |
| Total Assets | $22.7M | -72.8% |
| Current Liabilities | $25.2M | +203.6% |
| Long-term Debt | $20.4M | -8.3% |
| Total Liabilities | $33.4M | +27.4% |
| Stockholders' Equity | -$10.6M | -118.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.6M | -25.7% |
| Financing Cash Flow | -$1.6M | -101.4% |